Copy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunil Healthcare Ltd has published its audited Q4 and full-year FY 2025-26 financial results in the Pioneer newspaper on May 31, 2026. Full-year net sales stood at ₹87.23 Crore, EBITDA at ₹11.86 Crore (13.61% margin), and profit after tax at ₹4.05 Crore with an EPS of ₹2.48. Q4 standalone net sales were ₹16.11 Crore. The company manufactures formulations across three units: Bajaj Healthcare, Hindustan Pharmacy, and an Ayurvedic/cosmeceuticals division. Total debt stood at ₹15 Crore. The Board meeting to approve results was held on May 30, 2026. The auditor's report is unqualified.
Steady full-year performance with modest profitability; Q4 revenue appears seasonally lower, but annual net sales growth versus prior year reflects stable operations. No red flags in the unqualified audit report.